Merck (MRK) Exchange Rate Effect (2009 - 2026)
Merck (MRK) posted quarterly Exchange Rate Effect of -$19.0 million for Q1 2026, down 112.18% YoY from $156.0 million in Q1 2025, and down 182.61% sequentially from $23.0 million in Q4 2025.
Merck (MRK) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Merck has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$19.0 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 112.18% year-over-year to -$19.0 million; the TTM figure through Mar 2026 stood at $388.0 million (up 38700.0% YoY), while the FY2025 annual figure was $563.0 million, up 292.15% from the prior year.
- Exchange Rate Effect fell to -$19.0 million in Q1 2026, from $23.0 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for MRK reached as high as $374.0 million in Q2 2025 and fell as low as -$412.0 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$19.0 million (2026), against an average of -$8.0 million.
- The widest YoY moves for Exchange Rate Effect: up 638.24% in 2022, down 795.65% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at $366.0 million in 2022, then plunged by 49.18% to $186.0 million in 2023, then plunged by 297.31% to -$367.0 million in 2024, then jumped by 106.27% to $23.0 million in 2025, then slumped by 182.61% to -$19.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$19.0 million, $23.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 67.00 Mn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -25.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -12.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -18.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -77.00 Mn |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | -18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.00 Mn |
| Mar 31, 2026 | -19.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 374.00 Mn |
| Jun 30, 2025 | 374.00 Mn |
| Mar 31, 2025 | 156.00 Mn |
| Mar 31, 2025 | 156.00 Mn |
| Dec 31, 2024 | -367.00 Mn |
| Dec 31, 2024 | -367.00 Mn |
| Sep 30, 2024 | 294.00 Mn |
| Sep 30, 2024 | 294.00 Mn |
| Jun 30, 2024 | -82.00 Mn |
| Jun 30, 2024 | -82.00 Mn |
| Mar 31, 2024 | -138.00 Mn |
| Mar 31, 2024 | -138.00 Mn |
| Dec 31, 2023 | 186.00 Mn |
| Dec 31, 2023 | 186.00 Mn |